Product category:
Laboratory information management system (LIMS)
News Release from: Quality Systems International (UK) | Subject: Winlims
Edited by the Laboratorytalk Editorial
Team on 06 October 2004
Lims solutions for the pharmaceutical
industry
New facilities include enhanced audit trails and security controls to suit application in tightly regulated pharmaceutical laboratories
The pharmaceutical industry is one of the most tightly regulated in the world The audits carried out on pharmaceutical companies will scrutinise not only their laboratory procedures, but also any Lims systems in use
This article was originally published on Laboratorytalk on 18 Dec 2006 at 8.00am (UK)
Related stories
Winlims rental pays for itself
Cost savings achieved by the introduction of Winlims to a typical laboratory easily exceed the monthly payments required under the new Winlims Rental scheme
Enhanced calculation power for Lims
Latest release incorporate a new calculation engine with greatly enhanced flexibility and functionality offering powerful new tools for laboratory data management
Recent software enhancements to QSI's Winlims package provide additional tools to aid regulatory adherence.
Recently announced at the QSI European User Group meeting, held at the company's new European headquarters near Aylesbury, UK, these new facilities include enhanced audit trails and security controls.
The audit trailing logs every change made to a data record, be that changing a value, data deletion or any other modification, and also registers the circumstances of the change - who made it, when and why.
The security facilities enable comprehensive configuration of privileges, and include facilities like the detection of failed login attempts and monitoring staff training levels - so that an unqualified person would not be allowed to process a particular method, for example.
Also included is a facility for version control of specifications and methods, enabling precise identification of the quality controls that were in place at any time in the past.
The use of electronic signatures to authorise transactions is covered by the FDA's 21 CFR Part 11.
Winlims provides facilities for configuring and applying electronic signatures in excess of the regulatory requirement.
Other facilities for the pharmaceutical laboratory include the shelf-life testing option that holds user-defined testing protocols and informs the laboratory when to withdraw samples from storage for testing.
Formulation management, and complaints and corrective actions, are other tools that used with the Winlims core functionality, provide a unique solution for pharmaceutical laboratory without the need for extensive custom code.
• Quality Systems International (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
